News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,885 Results
Type
Article (1811)
Company Profile (5)
Press Release (37069)
Section
Business (15656)
Career Advice (80)
Deals (2771)
Drug Delivery (5)
Drug Development (3895)
Employer Resources (3)
FDA (791)
Job Trends (825)
News (22238)
Policy (1211)
Tag
Academia (50)
Accelerated approval (2)
Adcomms (1)
Allergies (7)
Alliances (1531)
ALS (11)
Alzheimer's disease (68)
Antibody-drug conjugate (ADC) (22)
Approvals (836)
Artificial intelligence (24)
Autoimmune disease (8)
Automation (1)
Bankruptcy (15)
Best Places to Work (680)
Biosimilars (6)
Biotechnology (3)
Bladder cancer (11)
Brain cancer (1)
Breast cancer (73)
Cancer (346)
Cardiovascular disease (28)
Career advice (72)
Career pathing (2)
CAR-T (5)
CDC (1)
Cell therapy (28)
Cervical cancer (2)
Clinical research (3736)
Collaboration (63)
Compensation (65)
Complete response letters (1)
COVID-19 (66)
C-suite (14)
Cystic fibrosis (7)
Data (449)
Depression (5)
Diabetes (37)
Diagnostics (411)
Digital health (3)
Diversity, equity & inclusion (1)
Drug discovery (7)
Drug pricing (9)
Drug shortages (3)
Duchenne muscular dystrophy (12)
Earnings (14323)
Editorial (1)
Employer resources (2)
Events (3860)
Executive appointments (21)
FDA (1082)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (64)
Gene editing (6)
Generative AI (1)
Gene therapy (21)
GLP-1 (67)
Government (115)
Guidances (147)
Healthcare (1044)
HIV (9)
IgA nephropathy (1)
Immunology and inflammation (12)
Immuno-oncology (2)
Indications (11)
Infectious disease (81)
Inflammatory bowel disease (18)
Influenza (4)
Intellectual property (17)
Interviews (20)
IPO (1917)
Job creations (192)
Job search strategy (43)
JPM (5)
Kidney cancer (1)
Labor market (11)
Layoffs (36)
Legal (253)
Liver cancer (2)
Lung cancer (60)
Lymphoma (50)
Manufacturing (41)
MASH (9)
Medical device (854)
Medtech (860)
Mergers & acquisitions (900)
Metabolic disorders (93)
mRNA (6)
Multiple sclerosis (16)
NASH (1)
Neurodegenerative disease (11)
Neuropsychiatric disorders (5)
Neuroscience (135)
NextGen: Class of 2026 (229)
Non-profit (127)
Obesity (48)
Opinion (4)
Ovarian cancer (10)
Pain (8)
Pancreatic cancer (20)
Parkinson's disease (9)
Partnered (1)
Patents (28)
Patient recruitment (7)
Peanut (4)
People (1132)
Pharmacy benefit managers (1)
Phase 1 (857)
Phase 2 (1548)
Phase 3 (1530)
Pipeline (909)
Policy (3)
Postmarket research (178)
Preclinical (269)
Press Release (1)
Prostate cancer (6)
Psychedelics (2)
Radiopharmaceuticals (14)
Rare diseases (37)
Real estate (204)
Recruiting (2)
Regulatory (1060)
Reports (5)
Research institute (55)
Resumes & cover letters (20)
RSV (4)
Schizophrenia (15)
Series A (5)
Series B (6)
Service/supplier (1)
Sickle cell disease (5)
Spinal muscular atrophy (17)
Startups (128)
Stomach cancer (1)
Supply chain (2)
Tariffs (4)
The Weekly (1)
Vaccines (20)
Venture capital (7)
Weight loss (32)
Women's health (6)
Date
Last 7 days (57)
Last 30 days (266)
Last 365 days (2332)
2026 (460)
2025 (2290)
2024 (2553)
2023 (2683)
2022 (3033)
2021 (3030)
2020 (2816)
2019 (2109)
2018 (1733)
2017 (1544)
2016 (1167)
2015 (1394)
2014 (990)
2013 (690)
2012 (729)
2011 (844)
2010 (6529)
Location
Africa (29)
Alabama (4)
Arizona (13)
Asia (2149)
Australia (229)
California (879)
Canada (214)
China (63)
Colorado (39)
Connecticut (37)
Delaware (73)
Europe (4958)
Florida (107)
Georgia (32)
Idaho (4)
Illinois (78)
India (5)
Indiana (83)
Japan (38)
Kansas (7)
Kentucky (5)
Louisiana (6)
Maine (8)
Maryland (89)
Massachusetts (520)
Michigan (23)
Minnesota (38)
Missouri (5)
Montana (2)
Nebraska (1)
Nevada (4)
New Hampshire (10)
New Jersey (300)
New Mexico (2)
New York (278)
North Carolina (102)
Northern California (498)
Ohio (21)
Oregon (2)
Pennsylvania (187)
Puerto Rico (2)
Rhode Island (1)
South America (60)
South Carolina (5)
Southern California (302)
Tennessee (9)
Texas (109)
United States (3107)
Utah (31)
Virginia (12)
Washington D.C. (2)
Washington State (62)
Wisconsin (7)
38,885 Results for "125".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
J&J Stops Mid-stage Eczema Trial as $1.25B Asset Misses Efficacy Mark
J&J paid Numab Therapeutics $1.25 billion upfront for the asset in 2024 based on the belief that its dual mechanism of action could improve on existing therapies.
January 5, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Evommune Announces $125 Million Private Placement
February 12, 2026
·
5 min read
Press Releases
Five Global Teams Awarded $125 Million to Take on the Toughest Challenges at the Frontiers of Cancer Science
March 4, 2026
·
11 min read
Press Releases
Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and Pre-Funded Warrants
February 25, 2026
·
4 min read
Press Releases
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.
January 21, 2026
·
10 min read
Press Releases
Immatics Announces $125 Million Underwritten Offering
December 5, 2025
·
3 min read
Press Releases
ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative
March 2, 2026
·
5 min read
Venture capital
Ambros Launches With $125M To Bring Italian Non-Opioid Pain Drug to America
Ambros Therapeutics’ non-opioid bisphosphonate analgesic, already approved in Italy, will soon begin a pivotal test in the U.S.
December 16, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Amphix Bio raises $12.5M seed round to advance peptide drug platform
December 19, 2025
·
2 min read
Press Releases
Diagonal Therapeutics Announces Oversubscribed $125 Million Series B Financing to Advance Clinical Development of Disease-Modifying, Clustering Antibody Pipeline
January 8, 2026
·
5 min read
1 of 3,889
Next
